These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 26230099)

  • 61. Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity.
    Carlucci C; Petrof EO; Allen-Vercoe E
    EBioMedicine; 2016 Nov; 13():37-45. PubMed ID: 27720396
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The adaptive immune response to Clostridioides difficile: A tricky balance between immunoprotection and immunopathogenesis.
    Hernández Del Pino RE; Barbero AM; Español LÁ; Morro LS; Pasquinelli V
    J Leukoc Biol; 2021 Jan; 109(1):195-210. PubMed ID: 32829520
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection.
    Jalanka J; Mattila E; Jouhten H; Hartman J; de Vos WM; Arkkila P; Satokari R
    BMC Med; 2016 Oct; 14(1):155. PubMed ID: 27724956
    [TBL] [Abstract][Full Text] [Related]  

  • 64. No appendix necessary: Fecal transplants and antibiotics can resolve Clostridium difficile infection.
    Joshi T; Elderd BD; Abbott KC
    J Theor Biol; 2018 Apr; 442():139-148. PubMed ID: 29355542
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A new role for heat shock factor 27 in the pathophysiology of
    Yanda MK; Guggino WB; Cebotaru L
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G120-G129. PubMed ID: 31709831
    [No Abstract]   [Full Text] [Related]  

  • 66. Antibiotic-Induced Alterations of the Murine Gut Microbiota and Subsequent Effects on Colonization Resistance against Clostridium difficile.
    Schubert AM; Sinani H; Schloss PD
    mBio; 2015 Jul; 6(4):e00974. PubMed ID: 26173701
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Neutrophil-mediated inflammation in the pathogenesis of Clostridium difficile infections.
    Jose S; Madan R
    Anaerobe; 2016 Oct; 41():85-90. PubMed ID: 27063896
    [TBL] [Abstract][Full Text] [Related]  

  • 68.
    Deng H; Yang S; Zhang Y; Qian K; Zhang Z; Liu Y; Wang Y; Bai Y; Fan H; Zhao X; Zhi F
    Front Microbiol; 2018; 9():2976. PubMed ID: 30619112
    [No Abstract]   [Full Text] [Related]  

  • 69. An Integrated Metabolomic and Microbiome Analysis Identified Specific Gut Microbiota Associated with Fecal Cholesterol and Coprostanol in Clostridium difficile Infection.
    Antharam VC; McEwen DC; Garrett TJ; Dossey AT; Li EC; Kozlov AN; Mesbah Z; Wang GP
    PLoS One; 2016; 11(2):e0148824. PubMed ID: 26871580
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Successional Dynamics in the Gut Microbiome Determine the Success of
    Jurburg SD; Cornelissen JJBWJ; de Boer P; Smits MA; Rebel JMJ
    Front Cell Infect Microbiol; 2019; 9():271. PubMed ID: 31448240
    [No Abstract]   [Full Text] [Related]  

  • 71. Clostridium difficile flagellin FliC: Evaluation as adjuvant and use in a mucosal vaccine against Clostridium difficile.
    Bruxelle JF; Mizrahi A; Hoÿs S; Collignon A; Janoir C; Péchiné S
    PLoS One; 2017; 12(11):e0187212. PubMed ID: 29176760
    [TBL] [Abstract][Full Text] [Related]  

  • 72. What's metal got to do with it? Transition metals in Clostridioides difficile infection.
    Gomez SY; Patel J; Lopez CA
    Curr Opin Microbiol; 2022 Feb; 65():116-122. PubMed ID: 34839238
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-term microbiota and virome in a Zürich patient after fecal transplantation against Clostridium difficile infection.
    Broecker F; Klumpp J; Moelling K
    Ann N Y Acad Sci; 2016 May; 1372(1):29-41. PubMed ID: 27286042
    [TBL] [Abstract][Full Text] [Related]  

  • 74. MiniBioReactor Arrays (MBRAs) as a Tool for Studying C. difficile Physiology in the Presence of a Complex Community.
    Auchtung JM; Robinson CD; Farrell K; Britton RA
    Methods Mol Biol; 2016; 1476():235-58. PubMed ID: 27507346
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Innate Immune Response and Outcome of Clostridium difficile Infection Are Dependent on Fecal Bacterial Composition in the Aged Host.
    Shin JH; Gao Y; Moore JH; Bolick DT; Kolling GL; Wu M; Warren CA
    J Infect Dis; 2018 Jan; 217(2):188-197. PubMed ID: 28968660
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Models for the study of Clostridium difficile infection.
    Best EL; Freeman J; Wilcox MH
    Gut Microbes; 2012; 3(2):145-67. PubMed ID: 22555466
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fecal microbiota transplantation for the management of Clostridium difficile infection.
    Rao K; Young VB
    Infect Dis Clin North Am; 2015 Mar; 29(1):109-22. PubMed ID: 25677705
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Molecular features of lipoprotein CD0873: A potential vaccine against the human pathogen
    Bradshaw WJ; Bruxelle JF; Kovacs-Simon A; Harmer NJ; Janoir C; Péchiné S; Acharya KR; Michell SL
    J Biol Chem; 2019 Oct; 294(43):15850-15861. PubMed ID: 31420448
    [No Abstract]   [Full Text] [Related]  

  • 79. Oral Candida administration in a Clostridium difficile mouse model worsens disease severity but is attenuated by Bifidobacterium.
    Panpetch W; Somboonna N; Palasuk M; Hiengrach P; Finkelman M; Tumwasorn S; Leelahavanichkul A
    PLoS One; 2019; 14(1):e0210798. PubMed ID: 30645630
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Impact of Oral Fidaxomicin Administration on the Intestinal Microbiota and Susceptibility to Clostridium difficile Colonization in Mice.
    Ajami NJ; Cope JL; Wong MC; Petrosino JF; Chesnel L
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463537
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.